Tartrate-resistant acid phosphatase 5a and 5b contain distinct sugar moieties

Clinical Biochemistry

Volumn 41, Issue 14-15, 2008, Pages 1245-1249

  Kawaguchi, Takeshi ^a   Nakano, Takanari ^a   Sasagawa, Kumiko ^b   Ohashi, Tatsuya ^b   Miura, Toshihide ^b   Komoda, Tsugikazu ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b Nitto Boseki Co Ltd   (Japan)

Author keywords

Heterogeneity; Isoforms; Sugar chains; Tartrate resistant acid phosphatase (TRAP)

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; SIALIC ACID; SUGAR; TARTRATE RESISTANT ACID PHOSPHATASE 5A; TARTRATE RESISTANT ACID PHOSPHATASE 5B; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL COMPOSITION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME PURIFICATION; ENZYME STRUCTURE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ACID PHOSPHATASE; CARBOHYDRATES; CHROMATOGRAPHY, AFFINITY; HUMANS; ISOENZYMES; LECTINS;

EID: 55649099030     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.07.010     Document Type: Article

References (17)

1. Miyazaki T., Matsunaga T., Miyazaki S., Hokari S., and Komoda T. Changes in receptor activator of nuclear factor-kappaB, and its ligand, osteoprotegerin, bone-type alkaline phosphatase, and tartrate-resistant acid phosphatase in ovariectomized rats. J. Cell. Biochem. 93 3 (2004 Oct 15) 503-512
2. Mountzios G., Dimopoulos M.A., Bamias A., et al. Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton. Acta. Oncol. 46 2 (2007) 221-229
3. Halleen J.M., Alatalo S.L., Janckila A.J., Woitge H.W., Seibel M.J., and Vaananen H.K. Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption. Clin. Chem. 47 3 (2001 Mar) 597-600
4. Ek-Rylander B., Bill P., Norgard M., Nilsson S., and Andersson G. Cloning, sequence, and developmental expression of a type 5, tartrate-resistant, acid phosphatase of rat bone. J. Biol. Chem. 266 36 (1991 Dec 25) 24684-24689
5. Hayman A.R., Dryden A.J., Chambers T.J., and Warburton M.J. Tartrate-resistant acid phosphatase from human osteoclastomas is translated as a single polypeptide. Biochem. J. 277 Pt 3 (1991 Aug 1) 631-634
6. Wang Y., Norgard M., and Andersson G. N-glycosylation influences the latency and catalytic properties of mammalian purple acid phosphatase. Arch. Biochem. Biophys. 435 1 (2005 Mar 1) 147-156
7. Igarashi Y., Lee M.Y., and Matsuzaki S. Acid phosphatases as markers of bone metabolism. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 781 1-2 (2002 Dec 5) 345-358
8. Saunders P.T., Renegar R.H., Raub T.J., et al. The carbohydrate structure of porcine uteroferrin and the role of the high mannose chains in promoting uptake by the reticuloendothelial cells of the fetal liver. J. Biol. Chem. 260 6 (1985 Mar 25) 3658-3665
9. Lam W.K., Eastlund D.T., Li C.Y., and Yam L.T. Biochemical properties of tartrate-resistant acid phosphatase in serum of adults and children. Clin. Chem. 24 7 (1978 Jul) 1105-1108
10. Halleen J., Hentunen T.A., Hellman J., and Vaananen H.K. Tartrate-resistant acid phosphatase from human bone: purification and development of an immunoassay. J. Bone. Miner. Res. 11 10 (1996 Oct) 1444-1452
11. Lam K.W., Li C.Y., Yam L.T., and Desnick R.J. Comparison of the tartrate-resistant acid phosphatase in Gaucher's disease and leukemic reticuloendotheliosis. Clin. Biochem. 14 4 (1981 Aug) 177-181
12. Funhoff E.G., Ljusberg J., Wang Y., Andersson G., and Averill B.A. Mutational analysis of the interaction between active site residues and the loop region in mammalian purple acid phosphatases. Biochemistry 40 38 (2001 Sep 25) 11614-11622
13. Ohashi T., Igarashi Y., Mochizuki Y., et al. Development of a novel fragments absorbed immunocapture enzyme assay system for tartrate-resistant acid phosphatase 5b. Clin. Chim. Acta. 376 1-2 (2007 Feb) 205-212
14. Ljusberg J., Wang Y., Lang P., et al. Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts. J. Biol. Chem. 280 31 (2005 Aug 5) 28370-28381
15. Terpos E., Politou M., and Rahemtulla A. The role of markers of bone remodeling in multiple myeloma. Blood. Rev. 19 3 (2005 May) 125-142
16. Jung K., Lein M., Stephan C., et al. Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications. Int. J. Cancer. 111 5 (2004 Sep 20) 783-791
17. Terpos E., de la Fuente J., Szydlo R., et al. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma. Int. J. Cancer. 106 3 (2003 Sep 1) 455-457